News
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
Hims & Hers Health Inc. posted better-than-expected first-quarter revenue as the company pivots away from making copycat ...
4h
Her Campus on MSNWhat Gen Z College Students Need To Know About GLP-1s & Weight Loss SurgeryWeight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
9h
inews.co.uk on MSNInterest in weight-loss jabs is surging – here’s what semaglutide does to your bodyLast year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...
NAUSEA, constipation, breathing problems, racing heart… the list of Ozempic side effects appears to be growing by the day.
Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...
Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft ...
Decades of studies and statistics have shown that women are consistently held back in the workplace because of their gender.
You’ve probably been there — staring at another diet plan, another gym ad, another promise of results. And if you’ve ever ...
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results